In Conversation

Although the [pharma] industry is profit-driven, we should expect them to take some social responsibility and not ask for more than is reasonable. A short-term focus…

Health and wealth are connected. That is something we need to realise more in this country

Our cancer vaccine is allogenic and off the shelf, we are using the same product for any patient and we have a very scalable manufacturing platform…

Our core competency is pharmaceutical care

Digitalisation stands to radically improve the highly bureaucratic healthcare system to create something faster and more flexible

Currently, much of the valuable information about what patients go through remains hidden and underutilized

The Greek authorities should try to find a balance which provides drugs to a wider segment of the population but does not put the entire bill…

In oncology, we are moving up a gear to become a more focused and innovative player

The patient must be more central in everything we do; in speeding up procedures and access to medicine, and ensuring access to the best possible care

If a health system cannot support patients psychologically, existentially, and socially – in addition to physically – then it is not serving its purpose, regardless of…

At the European level, we would like to share our knowledge regarding the definition and assessment of unmet medical needs, which should not be predominantly driven…

Improving the evaluation process is crucial to ensure that real breakthrough innovative therapies can pass this stage and enter the pricing discussion

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here